| Literature DB >> 28508599 |
Catalina Cabrera-Salcedo1, Priya Kumar1, Vivian Hwa1, Andrew Dauber1.
Abstract
CDKN1C is a cyclin-dependent kinase Inhibitor and negative regulator of cellular proliferation. Recently, gain-of-function mutations in the PCNA domain of CDKN1C have been reported as the genetic basis of various growth-retarded syndromes including IMAGe syndrome, Russell Silver syndrome as well as a novel undergrowth syndrome that additionally exhibited early adulthood onset diabetes. This review summarizes the key clinical features and the molecular advances that have contributed to our understanding of this complex phenotypic spectrum. Copyright© of YS Medical Media ltd.Entities:
Keywords: Adrenal hypoplasia; CDKN1C; IMAGe syndrome; Intrauterine growth restriction
Mesh:
Substances:
Year: 2017 PMID: 28508599 DOI: 10.17458/per.vol14.2017.SKHD.imageandrelatedundergrowth
Source DB: PubMed Journal: Pediatr Endocrinol Rev ISSN: 1565-4753